person

Melinda K.

Country
Romania
Department
Cardiologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
72
Sites with multiple studies

Has run more than one trial at 72 of 555 partner sites.

Specializations

Cardiovascular disease and heart failure

Dan Luchian is involved in clinical research centered on atherosclerotic cardiovascular disease, atrial fibrillation, acute myocardial infarction, hypertension, and heart failure, with interest in prevention of recurrent ischemic and thromboembolic events.

  • Stroke prevention in atrial fibrillation
  • Cardiovascular risk reduction
  • Heart failure with kidney impairment
  • Acute coronary syndromes

His work also includes therapies aimed at reducing cardiovascular events in patients with established disease or high cardiometabolic risk.

Liver disease and metabolic dysfunction

His research landscape includes non-alcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease, and overweight or obesity with type 2 diabetes, reflecting a strong therapeutic focus on metabolic liver disorders.

  • NASH with fibrosis
  • MASLD
  • Weight management in diabetes
  • Liver histology and clinical liver outcomes

He is active in studies addressing progression of fatty liver disease alongside metabolic and cardiovascular comorbidity.

Oncology and lung cancer

As a medical oncology investigator, Dan Luchian is engaged in studies of non-small cell lung cancer, including tumors with uncommon EGFR mutations, as well as HER2-positive breast cancer.

  • NSCLC after surgery
  • Uncommon EGFR-mutated lung cancer
  • HER2-positive metastatic breast cancer
  • Post-treatment disease control

His trial portfolio also extends to immuno-oncology and targeted treatment strategies in solid tumors.

Inflammatory bowel disease and gastrointestinal inflammation

His clinical research includes ulcerative colitis, with attention to therapies for moderately to severely active disease and induction of clinical response.

  • Ulcerative colitis
  • Intestinal inflammation
  • Clinical remission
  • Maintenance of disease control

This area adds a gastrointestinal dimension to his broader therapeutic involvement.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.